临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2014年
7期
887-888
,共2页
孤立肾%经皮肾镜取石术%输尿管软镜
孤立腎%經皮腎鏡取石術%輸尿管軟鏡
고립신%경피신경취석술%수뇨관연경
Solitary kidney%Percutaneous nephrolithotomy%Retrograde intrarenal surgery
目的:观察一期经皮肾镜取石术(PCNL)联合二期输尿管软镜手术(RIRS)治疗孤立肾复杂性结石的临床疗效观察。方法回顾分析我科收治的64例孤立肾复杂性结石患者,随机分为观察组和对照组,每组32例。观察组患者在全麻下行PCNL联合RIRS治疗。对照组患者在全麻下行PCNL治疗,术后残留结石者行体外冲击波碎石治疗(ESWL)。两组患者均于术后3个月复查KUB或B超评估结石清除率并评估肾功能恢复情况。结果两组患者经过治疗后均取得满意疗效,观察组患者治疗总有效率96.9%,明显高于对照组75.0%,差异具有统计学意义(P<0.05);两组患者治疗后血肌酐为均明显降低,观察组指标明显优于对照组(P<0.05);两组患者在手术总时间和并发症发生率方面未见明显差异(P>0.05)。结论一期PCNL联合二期RIRS治疗孤立肾复杂性结石疗效确切、结石清除率高,具有良好的安全性,值得临床推广。
目的:觀察一期經皮腎鏡取石術(PCNL)聯閤二期輸尿管軟鏡手術(RIRS)治療孤立腎複雜性結石的臨床療效觀察。方法迴顧分析我科收治的64例孤立腎複雜性結石患者,隨機分為觀察組和對照組,每組32例。觀察組患者在全痳下行PCNL聯閤RIRS治療。對照組患者在全痳下行PCNL治療,術後殘留結石者行體外遲擊波碎石治療(ESWL)。兩組患者均于術後3箇月複查KUB或B超評估結石清除率併評估腎功能恢複情況。結果兩組患者經過治療後均取得滿意療效,觀察組患者治療總有效率96.9%,明顯高于對照組75.0%,差異具有統計學意義(P<0.05);兩組患者治療後血肌酐為均明顯降低,觀察組指標明顯優于對照組(P<0.05);兩組患者在手術總時間和併髮癥髮生率方麵未見明顯差異(P>0.05)。結論一期PCNL聯閤二期RIRS治療孤立腎複雜性結石療效確切、結石清除率高,具有良好的安全性,值得臨床推廣。
목적:관찰일기경피신경취석술(PCNL)연합이기수뇨관연경수술(RIRS)치료고립신복잡성결석적림상료효관찰。방법회고분석아과수치적64례고립신복잡성결석환자,수궤분위관찰조화대조조,매조32례。관찰조환자재전마하행PCNL연합RIRS치료。대조조환자재전마하행PCNL치료,술후잔류결석자행체외충격파쇄석치료(ESWL)。량조환자균우술후3개월복사KUB혹B초평고결석청제솔병평고신공능회복정황。결과량조환자경과치료후균취득만의료효,관찰조환자치료총유효솔96.9%,명현고우대조조75.0%,차이구유통계학의의(P<0.05);량조환자치료후혈기항위균명현강저,관찰조지표명현우우대조조(P<0.05);량조환자재수술총시간화병발증발생솔방면미견명현차이(P>0.05)。결론일기PCNL연합이기RIRS치료고립신복잡성결석료효학절、결석청제솔고,구유량호적안전성,치득림상추엄。
Objective To observe the clinical efficacy of percutaneous nephrolithotomy (PCNL) combined with retrograde intrarenal surgery (RIRS) to treat the complex renal stones in solitary kidneys. Methods 64 cases with complex renal stones in solitary kidneys were randomly divided into observation group and control group, with 32 patients each. The patients in observation group were treated by PCNL combined with RIRS. The control group was treated by PCNL and ESWL if needed. The stone clearance rate and renal function were observed 3 months after treatment by the KUB or B ultrasound. Results After the therapy, the two groups were significantly improved. The total effective rate in the observation group (96.9%) was significantly higher than the control group (75.0%). The serum creatinine in the observation group reduced more than the control group (P <0.05). The side effects had no difference between the two groups (P >0.05). Conclusions PCNL combined with RIRS could be an effective and safe option for complex stones in solitary kidneys and is worthy of clinical application.